Brown Advisory’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Brown Advisory’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,490	Closed	-$529K	–	962
2015 Q2	$529K	Sell	8,490 -2,900	-25%	-$181K	﹤0.01%	632
2015 Q1	$703K	Hold	11,390	–	–	﹤0.01%	620
2014 Q4	$615K	Hold	11,390	–	–	﹤0.01%	647
2014 Q3	$604K	Sell	11,390 -800	-7%	-$40.7K	﹤0.01%	639
2014 Q2	$633K	Buy	12,190 +800	+7%	+$38.6K	﹤0.01%	633
2014 Q1	$533K	Hold	11,390	–	–	﹤0.01%	652
2013 Q4	$501K	Hold	11,390	–	–	﹤0.01%	646
2013 Q3	$438K	Hold	11,390	–	–	﹤0.01%	648
2013 Q2	$401K	Buy	+11,390	New	+$385K	﹤0.01%	637

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Brown Advisory's XPH Position: Q3 2015 in Review

Brown Advisory sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 8,490 shares — an estimated $529K sold.

Brown Advisory first reported a position in XPH in Q2 2013 and held it in 9 quarters. The position peaked at $703K in Q1 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.

Brown Advisory reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Brown Advisory sold 8,490 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $529K.
Brown Advisory first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 9 quarters.
Brown Advisory's State Street SPDR S&P Pharmaceuticals ETF position peaked at $703K in Q1 2015.
77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.

Based on Brown Advisory's 13F filing for Q3 2015, filed 13 Nov 2015.